Page 46 | Certara

Publication

Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody

The article titled "Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a…

CertaraNovember 4, 2024

Conference

JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

We’re excited to participate in JSCPT 2025 in Tokyo, The 46th Annual Scientific Meeting of…

CertaraOctober 31, 2024

Case Study

Clinical Candidate Selection

In this case study, we look at an example of targeting a membrane bound protein…

CertaraOctober 31, 2024

Case Study

Phase 1 Interim Analysis

In this case study, we continue to work with the model and analysis from Immuno-modulation…

CertaraOctober 31, 2024

On-Demand Webinar

Improved Translation of Clinical TCE Dosing with Mechanistic Modeling

Abstract: Regulatory agencies recommend quantitative justifications for clinical dose selection. T-cell engagers (TCE) pose particular…

CertaraOctober 31, 2024

On-Demand Webinar

Applications of a QSP Model of LNP mRNA Delivery for the Treatment of Crigler-Najjar Syndrome Type 1

Abstract: Crigler-Najjar syndrome type 1 (CN1) is an autosomal recessive disease caused by a marked…

CertaraOctober 31, 2024

On-Demand Webinar

Guiding Target and Lead Optimization for a Molecular Glue Degrader

Learn how to optimize drug properties for protein degrader therapeutics by exploring system characteristics.

CertaraOctober 31, 2024

On-Demand Webinar

Capturing CAR T-cell Therapy Dynamics Through Mechanistic Modeling

Abstract: Chimeric antigen receptor T (CAR T)-cell therapy has shown remarkable success in treating various…

CertaraOctober 31, 2024

On-Demand Webinar

Physiologically Based Pharmacokinetic Modelling, an Integrative Approach to First in Human (FIH) Studies [APAC Webinar]

Physiologically Based Pharmacokinetic (PBPK) modelling is an integrative approach facilitating the optimal use of various…

CertaraOctober 31, 2024

Video

Part 5: Regulatory Outlook on Data Management

In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…

CertaraOctober 31, 2024

Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody

JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

Clinical Candidate Selection

Phase 1 Interim Analysis

Improved Translation of Clinical TCE Dosing with Mechanistic Modeling

Applications of a QSP Model of LNP mRNA Delivery for the Treatment of Crigler-Najjar Syndrome Type 1

Guiding Target and Lead Optimization for a Molecular Glue Degrader

Capturing CAR T-cell Therapy Dynamics Through Mechanistic Modeling

Physiologically Based Pharmacokinetic Modelling, an Integrative Approach to First in Human (FIH) Studies [APAC Webinar]

Part 5: Regulatory Outlook on Data Management

Newsletter sign up

Quick links

Solutions

Contact